# FDA 483 - Concord Biomedical Science and Emerging Technologies, Inc. - May 23, 2019

Source: https://www.keypedia.com/records/483/concord-biomedical-science-and-emerging-technologies-inc/ca57a28a-187a-4c2c-99cf-d893047229fd

> FDA 483 for Concord Biomedical Science and Emerging Technologies, Inc. on May 23, 2019. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Concord Biomedical Science and Emerging Technologies, Inc.
- Inspection Date: 2019-05-23
- Product Type: other
- Office Name: Division of Northeast Imports 
- Summary: Concord Biomedical Science and Emerging Technologies, Inc. in Lexington, MA, a nonclinical laboratory, was inspected by the FDA from May 15-23, 2019. The inspection revealed deficiencies related to the archiving of study data and documents, as well as failures to conduct nonclinical laboratory studies in accordance with established protocols. These issues indicate a lack of adherence to good laboratory practices.

## Related Officers

- [issuing_officer](https://www.keypedia.com/people/kent-a-conforti/8d3d3e82-cd97-420e-8840-df92d6eeba09)

Company: https://www.keypedia.com/companies/concord-biomedical-science-and-emerging-technologies-inc/3cfb5992-9173-4719-a830-87b6aff3626a

Office: https://www.keypedia.com/offices/division-of-northeast-imports/b20599cf-9797-41fd-947f-6589ef596a94